Northumbria University
UK, United Kingdom
NCT Number: NCT06932991
This retrospective, single-blind, parallel group study investigates the efficacy of Cognitive Stimulation Therapy (CST) compared to Reality Orientation and Reminiscence Therapy (RO&RM) in enhancing cognitive and functional domains in older adults with mild to moderate dementia.
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
UK, United Kingdom
Through data review, this retrospective, single-blind, parallel group study investigates the efficacy of Cognitive Stimulation Therapy (CST) compared to Reality Orientation and Reminiscence Therapy (RO&RM) in enhancing cognitive and functional domains in older adults with mild to moderate dementia.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
cognitive remediation
Time frame: Baseline line and six-month
Participants' attention and episodic memory were quantified using the Kendrick Cognitive Test for the Elderly (KCTE).
Time frame: Baseline and 6-month after the start of the program
for assessing executive function in older adults with dementia. Its focus on initiating, planning, and executing activities provides a practical and ecologically valid measure of executive dysfunction, aligning closely with the real-world challenges faced by older Chinese people with dementia.
Northumbria University
Other
Cognitive Stimulation Therapy vs. Reality Orientation & Reminiscence Therapy: Effects on Cognitive and Functional Domains in Dementia - Retrospective Study
Acronym: CST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06347172
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07306065
Alzheimer Disease, Alzheimers Disease
Orlando, Florida, United States
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT05529706
Alzheimer Disease, Brain Diseases
San Francisco, California, United States
View Trial Details